NO20082741L - Terapeutisk bruk av steroidale forbindelser - Google Patents
Terapeutisk bruk av steroidale forbindelserInfo
- Publication number
- NO20082741L NO20082741L NO20082741A NO20082741A NO20082741L NO 20082741 L NO20082741 L NO 20082741L NO 20082741 A NO20082741 A NO 20082741A NO 20082741 A NO20082741 A NO 20082741A NO 20082741 L NO20082741 L NO 20082741L
- Authority
- NO
- Norway
- Prior art keywords
- hydroxy
- androstene
- dione
- disease
- prevention
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0523550.2A GB0523550D0 (en) | 2005-11-18 | 2005-11-18 | Therapeutic uses of steroidal compounds |
PCT/GB2006/004305 WO2007057691A2 (fr) | 2005-11-18 | 2006-11-17 | Utilisations therapeutiques de composes steroides |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20082741L true NO20082741L (no) | 2008-07-23 |
Family
ID=35580318
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20082741A NO20082741L (no) | 2005-11-18 | 2008-06-17 | Terapeutisk bruk av steroidale forbindelser |
Country Status (16)
Country | Link |
---|---|
US (1) | US8846652B2 (fr) |
EP (1) | EP1948192A2 (fr) |
JP (1) | JP5395437B2 (fr) |
KR (1) | KR101314694B1 (fr) |
CN (1) | CN101346144B (fr) |
AU (1) | AU2006314226B2 (fr) |
CA (1) | CA2630441C (fr) |
GB (1) | GB0523550D0 (fr) |
IL (1) | IL191457A (fr) |
MX (1) | MX2008006440A (fr) |
NO (1) | NO20082741L (fr) |
NZ (1) | NZ568560A (fr) |
RU (1) | RU2427375C2 (fr) |
TW (1) | TWI386211B (fr) |
WO (1) | WO2007057691A2 (fr) |
ZA (1) | ZA200804266B (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CU20110244A7 (es) | 2011-12-27 | 2013-08-29 | Ct De Investigación Y Desarrollo De Medicamentos Cidem | Sistemas espiroesteroidales con efectos neuroactivos y anti-inflamatorios |
CN108434090A (zh) * | 2017-02-14 | 2018-08-24 | 高药品股份有限公司 | 以生理脂肪为基剂的类固醇药膏 |
RU2745868C9 (ru) * | 2020-05-28 | 2021-04-08 | Федеральное государственное бюджетное образовательное учреждение высшего образования «Национальный исследовательский Мордовский государственный университет им. Н.П. Огарёва» | Способ ускорения регенерационных процессов в поврежденных периферических нервах |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU1350792A (en) | 1991-01-16 | 1992-08-27 | General Hospital Corporation, The | Human galanin |
AU1462692A (en) | 1991-02-25 | 1992-09-15 | Board Of Regents Of The University Of Washington, The | Methods for detecting galanin antagonists |
CA2105572A1 (fr) | 1991-03-06 | 1992-09-07 | Helen F. Evans | Galanine humaine, clones d'adnc codant pour la galanine humaine et methode de production de galanine humaine |
SE9101472D0 (sv) | 1991-05-15 | 1991-05-15 | Trion Forskning & Utveckling | Galanin antagonist |
JPH06172387A (ja) | 1992-12-11 | 1994-06-21 | Aibaitsu Kk | 合成ペプチド誘導体 |
EP0698612B1 (fr) * | 1993-05-18 | 2001-07-25 | Ltt Institute Co., Ltd. | Promoteur d'osteogenese et remede contre l'osteoporose |
JPH09151197A (ja) * | 1995-11-29 | 1997-06-10 | L T T Kenkyusho:Kk | 自己免疫疾患治療薬 |
DK0918455T3 (da) | 1996-07-24 | 2003-08-04 | Neurotargets Ltd | Anvendelse af galanin til reparation af nerveskader |
JP2000169374A (ja) * | 1998-12-03 | 2000-06-20 | Ltt Kenkyusho:Kk | Igf増強剤 |
PE20010404A1 (es) * | 1999-06-11 | 2001-04-09 | Watson Pharmaceuticals Inc | Combinacion de esteroides androgenicos no orales y compuestos estrogenicos y su uso en mujeres |
GB0105772D0 (en) * | 2001-03-08 | 2001-04-25 | Sterix Ltd | Use |
DE60120104T2 (de) | 2001-03-20 | 2006-09-21 | Schwarz Pharma Ag | Neue Verwendung von Peptidverbindungen bei der Behandlung von nicht-neuropathischem Entzündungsschmerz |
WO2002096934A1 (fr) | 2001-05-25 | 2002-12-05 | Kemia, Inc. | Ligands non naturels du recepteur de la galanine |
RU2299729C2 (ru) | 2001-07-16 | 2007-05-27 | Орто-Макнейл Фармасьютикал, Инк. | Карбаматные соединения для применения для предотвращения или лечения невропатической боли и боли, связанной с кластерной и мигреневой головной болью |
JP2004538305A (ja) | 2001-07-31 | 2004-12-24 | ファルマシア・アンド・アップジョン・カンパニー | 3−ヘテロシクリル−及び3−シクロアルキル−3−アリールオキシプロパンアミンによる慢性疼痛の治療 |
JP2005500344A (ja) | 2001-07-31 | 2005-01-06 | ファルマシア・アンド・アップジョン・カンパニー | 3−アリールオキシ−3−フェニルプロパンアミンを用いた慢性疼痛の治療 |
DE60213116T2 (de) | 2001-10-16 | 2007-02-08 | Endo Pharmaceuticals Inc. | Verwendung von carbinolen zur behandlung von neuropathischer funktionsstörung |
GB0403509D0 (en) | 2004-02-17 | 2004-03-24 | Neuro Targets Ltd | Galanin receptors and brain injury |
GB0409498D0 (en) * | 2004-04-28 | 2004-06-02 | Hunter Fleming Ltd | Transdermal steroid formulation |
WO2007045027A1 (fr) * | 2005-10-19 | 2007-04-26 | Chavah Pty Ltd | Réduction des effets secondaires des inhibiteurs de l'aromatase employés dans le traitement du cancer du sein |
MX2009005753A (es) | 2006-11-30 | 2009-09-28 | Hunter Fleming Ltd | Modulacion de trayectorias metabolicas de prostaglandina/ciclooxig enasa. |
-
2005
- 2005-11-18 GB GBGB0523550.2A patent/GB0523550D0/en not_active Ceased
-
2006
- 2006-11-17 EP EP06808592A patent/EP1948192A2/fr not_active Withdrawn
- 2006-11-17 NZ NZ568560A patent/NZ568560A/en not_active IP Right Cessation
- 2006-11-17 KR KR1020087014690A patent/KR101314694B1/ko not_active IP Right Cessation
- 2006-11-17 CA CA2630441A patent/CA2630441C/fr not_active Expired - Fee Related
- 2006-11-17 CN CN2006800486827A patent/CN101346144B/zh not_active Expired - Fee Related
- 2006-11-17 AU AU2006314226A patent/AU2006314226B2/en not_active Ceased
- 2006-11-17 US US12/094,079 patent/US8846652B2/en not_active Expired - Fee Related
- 2006-11-17 RU RU2008124834/15A patent/RU2427375C2/ru not_active IP Right Cessation
- 2006-11-17 WO PCT/GB2006/004305 patent/WO2007057691A2/fr active Application Filing
- 2006-11-17 MX MX2008006440A patent/MX2008006440A/es active IP Right Grant
- 2006-11-17 JP JP2008540695A patent/JP5395437B2/ja not_active Expired - Fee Related
- 2006-11-20 TW TW095142777A patent/TWI386211B/zh not_active IP Right Cessation
-
2008
- 2008-05-15 IL IL191457A patent/IL191457A/en not_active IP Right Cessation
- 2008-05-16 ZA ZA200804266A patent/ZA200804266B/xx unknown
- 2008-06-17 NO NO20082741A patent/NO20082741L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2007057691A2 (fr) | 2007-05-24 |
GB0523550D0 (en) | 2005-12-28 |
CN101346144B (zh) | 2011-07-20 |
AU2006314226B2 (en) | 2012-02-02 |
NZ568560A (en) | 2010-11-26 |
TW200730180A (en) | 2007-08-16 |
RU2008124834A (ru) | 2009-12-27 |
IL191457A (en) | 2013-10-31 |
CN101346144A (zh) | 2009-01-14 |
CA2630441A1 (fr) | 2007-05-24 |
US20090227551A1 (en) | 2009-09-10 |
EP1948192A2 (fr) | 2008-07-30 |
AU2006314226A1 (en) | 2007-05-24 |
MX2008006440A (es) | 2008-12-01 |
IL191457A0 (en) | 2009-08-03 |
KR20080073755A (ko) | 2008-08-11 |
ZA200804266B (en) | 2009-01-28 |
JP2009515939A (ja) | 2009-04-16 |
TWI386211B (zh) | 2013-02-21 |
CA2630441C (fr) | 2013-10-29 |
US8846652B2 (en) | 2014-09-30 |
WO2007057691A3 (fr) | 2007-08-02 |
JP5395437B2 (ja) | 2014-01-22 |
RU2427375C2 (ru) | 2011-08-27 |
KR101314694B1 (ko) | 2013-10-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2009063202A3 (fr) | Utilisation de composés antagonistes de crth2 | |
NO20073465L (no) | Benzotiazol-derivater | |
MX2010007375A (es) | Nuevos derivados de lupano. | |
NO20073831L (no) | Medikamenter for behandling eller forebygging av fibrotiske sykdommer | |
NO20062370L (no) | Amidderivater | |
NO20083114L (no) | Polysykliske indazolderivater som er ERK-inhibitorer | |
NO20073730L (no) | Amidderivater | |
NO20050397L (no) | Tricykliske steroidhormonnukleaere reseptormodulatorer | |
WO2009047798A3 (fr) | Dérivés acétamide comme activateur de la glucokinase, leur procédé et applications médicinales | |
ZA200810113B (en) | Method for the treatment and prevention of ocular disorders | |
MX2008002061A (es) | Derivados de tiazolil piperidina utiles como moduladores del receptor h3. | |
NZ514981A (en) | Renin inhibitors | |
NO20064010L (no) | Indazolderivater og farmasoytiske preparater inneholdelse slike | |
NO20084516L (no) | Terfenylderivater for behandling av alzheimers sykdom | |
BRPI0921097B8 (pt) | composto ou seu sal farmaceuticamente aceitável, intermediário do composto, composição farmacêutica e uso do composto | |
UA96575C2 (en) | Process for the preparation of olmesartan medoxomil | |
ATE357453T1 (de) | Comt-inhibitoren | |
NO20034301L (no) | Cyano-substituerte dihydropyrimidin forbindelser | |
WO2008008701A3 (fr) | Composés thérapeutiques | |
IL195016A0 (en) | 1h-indol-5-yl-piperazin-1-yl-methanone derivatives | |
MX2007005073A (es) | Conjugados con actividad antiinflamtoria. | |
HRP20120231T1 (hr) | Upotreba derivata indola kao aktivatora nurr-1 u liječenju parkinsonove bolesti | |
NO20082741L (no) | Terapeutisk bruk av steroidale forbindelser | |
MX344556B (es) | Agonista de subtipo de receptor 5-ht1a. | |
IS8096A (is) | Notkun karbamasepínafleiða til að meðhöndla órósemi í sjúklingum er þjást af vitglöpum |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |